J7Z Analyst Ratings
Strong Buy
16 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
J7Z Stock 12 Month Forecast
Average Price Target
―| Highest Price Target$255.73 | Average Price Target$232.34 | Lowest Price Target$185.91 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgan Stanley
CHF229.75
Buy
―
Assigned
08/13/26
Truist Financial
―
Buy
―
Reiterated
08/11/26
UBS
CHF255.73
Buy
―
Reiterated
08/11/26
Canaccord Genuity
CHF243.56
Buy
―
Reiterated
08/11/26
Needham
CHF237.06
Buy
―
Reiterated
08/10/26
Bank of America Securities
CHF249.24
Buy
―
Reiterated
08/10/26
RBC Capital
CHF209.46→CHF221.64
Buy
―
Reiterated
08/10/26
Wells Fargo
CHF243.56
Buy
―
Reiterated
08/10/26
Barclays
CHF211.08→CHF219.2
Buy
―
Reiterated
08/04/26
TD Cowen
CHF223.26→CHF243.56
Buy
―
Assigned
08/04/26
Piper Sandler
CHF244.37→CHF251.67
Buy
―
Reiterated
08/04/26
Stifel Nicolaus
CHF186.73→CHF223.26
Buy
―
Reiterated
08/04/26
Deutsche Bank
CHF219.2→CHF233
Buy
―
Assigned
08/04/26
J.P. Morgan
CHF215.14→CHF224.07
Buy
―
Assigned
08/04/26
Robert W. Baird
CHF204.59→CHF227.32
Buy
―
Reiterated
08/04/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
CHF229.75
Buy
―
Assigned
08/13/26
Truist Financial
―
Buy
―
Reiterated
08/11/26
UBS
CHF255.73
Buy
―
Reiterated
08/11/26
Canaccord Genuity
CHF243.56
Buy
―
Reiterated
08/11/26
Needham
CHF237.06
Buy
―
Reiterated
08/10/26
Bank of America Securities
CHF249.24
Buy
―
Reiterated
08/10/26
RBC Capital
CHF209.46→CHF221.64
Buy
―
Reiterated
08/10/26
Wells Fargo
CHF243.56
Buy
―
Reiterated
08/10/26
Barclays
CHF211.08→CHF219.2
Buy
―
Reiterated
08/04/26
TD Cowen
CHF223.26→CHF243.56
Buy
―
Assigned
08/04/26
Piper Sandler
CHF244.37→CHF251.67
Buy
―
Reiterated
08/04/26
Stifel Nicolaus
CHF186.73→CHF223.26
Buy
―
Reiterated
08/04/26
Deutsche Bank
CHF219.2→CHF233
Buy
―
Assigned
08/04/26
J.P. Morgan
CHF215.14→CHF224.07
Buy
―
Assigned
08/04/26
Robert W. Baird
CHF204.59→CHF227.32
Buy
―
Reiterated
08/04/26
Best Analysts Covering Jazz Pharmaceuticals
3 Months
Success Rate
19/28 ratings generated profit
Average Return
+3.80%
Copying Jason Gerberry's trades and holding each position for 3 Months would result in 67.86% of your transactions generating a profit, with an average return of +3.80% per trade.
1 Year
Success Rate
19/21 ratings generated profit
Average Return
+41.53%
Copying Joseph Thome's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +41.53% per trade.
2 Years
Success Rate
20/21 ratings generated profit
Average Return
+76.35%
Copying Joseph Thome's trades and holding each position for 2 Years would result in 95.24% of your transactions generating a profit, with an average return of +76.35% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
J7Z Analyst Recommendation Trends
Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
22
25
31
35
42
Hold
0
2
4
4
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
27
35
39
44
Each month's total comprises the sum of three months' worth of ratings.
J7Z Financial Forecast
J7Z Stock Forecast FAQ
What is CH:J7Z’s average 12-month price target, according to analysts?
Based on analyst ratings, Jazz Pharmaceuticals’s 12-month average price target is 232.34.
What is CH:J7Z’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:J7Z, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Jazz Pharmaceuticals a Buy, Sell or Hold?
Jazz Pharmaceuticals has a consensus rating of Strong Buy, which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
What is Jazz Pharmaceuticals’s share price target?
The average share price target for Jazz Pharmaceuticals is 232.34. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $255.73 ,and the lowest forecast is $185.91. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is $255.73 ,and the lowest forecast is $185.91. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Jazz Pharmaceuticals?
Jazz Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of Jazz Pharmaceuticals?
To buy shares of CH:J7Z, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.